Tuesday, February 25, 2020

USFDA issues warning letter to Cipla for Goa manufacturing facility

USFDA issues warning letter to Cipla for Goa manufacturing facility The company further said that it remains committed to maintaining the highest standards of compliance and will work closely with the agency to comprehensively address all the observations

from Moneycontrol Business News https://ift.tt/2wNZJKI

No comments:

Post a Comment

FIIs ease bearish bets post-Budget, but charts warn of range-bound Nifty: Anand James

Foreign investors are reducing their negative bets on the market after the Budget. However, the market's overall sentiment remains delic...